Dual-peptide research blend containing CJC-1295 without DAC (Mod GRF 1-29) and Ipamorelin,
CJC-1295 without DAC is a modified GHRH analogue, also known as Mod GRF 1-29. Ipamorelin is a selective agonist of the growth hormone secretagogue receptor GHS-R1a. The blend is studied in laboratory and preclinical research models relating to growth-hormone signalling and interactions between the GHRH and GHS pathways. For laboratory research only. Not for human or veterinary use.
